Search found 531 matches
- Thu Dec 10, 2015 3:43 pm
- Forum: ImetelChat
- Topic: Take aways from Oppenheimer
- Replies: 6
- Views: 5461
Re: Take aways from Oppenheimer
Phil: agree with your observation. Dr. Scarlett didn't become too frenzy about it, probably because formally TI is not primary end point. But he clearly stated that they will measure everything they could in order to indicate the depth and nature of the responses. Clearly TI is a major one, in fact ...
- Thu Dec 10, 2015 9:23 am
- Forum: ImetelChat
- Topic: Welcome!
- Replies: 0
- Views: 3217
Welcome!
Dear all, thanks for joining this board. I highly value you as being members of the first hour! We'll try to keep this MB clean and honest. Hopefully it will become a place where people with various interests and backgrounds feel comfortable. There are some things that are important in making this p...
- Wed Dec 09, 2015 6:33 pm
- Forum: ImetelChat
- Topic: Take aways from Oppenheimer
- Replies: 6
- Views: 5461
Take aways from Oppenheimer
- IMerge contains already a Phase 3 protocol. The primary outcome is TI. IMegre is intended clearly as a registration enabling study. Expecting to see significant proportion of TI as well as symptomatic improvement. - the decisive argument for Tefferi as well as JnJ to put their cards on imetelstat ...
- Wed Dec 09, 2015 4:14 pm
- Forum: ImetelChat
- Topic: Fisher, you did it!!
- Replies: 6
- Views: 5175
Re: Fisher, you did it!!
Thanks for registering, Phil! Please feel free to provide your opinions and views here!
- Wed Dec 09, 2015 2:32 pm
- Forum: ImetelChat
- Topic: Zacks: Geron’s telomerase technology platform represents significant commercial opportunity
- Replies: 0
- Views: 3492
Zacks: Geron’s telomerase technology platform represents significant commercial opportunity
Zacks, 8 Dec 2015: Geron’s telomerase technology platform represents significant commercial opportunity. The successful development of products that target telomeres could very well change the treatment paradigm for several diseases including oncology, which represents significant commercial potenti...
- Wed Dec 09, 2015 1:44 pm
- Forum: ImetelChat
- Topic: Dr. Titia de Lange from the Rockefeller University Institute about telomeres and telomerase; very nice explanation
- Replies: 0
- Views: 3545
Dr. Titia de Lange from the Rockefeller University Institute about telomeres and telomerase; very nice explanation
Dr. Titia de Lange from the Rockefeller University Institute Australia speaks about telomeres and telomerase (recorded 30 May 2015). It is very nice and clear explanation. She speaks about the mechanisms of telomerase, including ageing. On 21.13 she elaborates on telomerase inhibition as a cancer th...
- Wed Dec 09, 2015 10:01 am
- Forum: ImetelChat
- Topic: Fisher, you did it!!
- Replies: 6
- Views: 5175
Re: Fisher, you did it!!
Hi BioPearl, thanks for registering and your supportive post. I hope this board will have good discussions and contributions. I will check DewDillegence as you suggest. I am looking forward to see how this board will evolve. Patients, investors, doctors and anyone interested should be safe and comfo...
- Tue Dec 08, 2015 1:21 pm
- Forum: ImetelChat
- Topic: Take aways from ASH2015
- Replies: 1
- Views: 2377
Take aways from ASH2015
by sdrawkcabeman (repost from Yahoo MB, 6 Dec 2015 1:12 PM) Points to drive home from the presentation The emphasis and growing chorus is that there’s a serious unmet need for MF/MDS/AML pts, and that’s the big push coalescing behind Imet. In the Q&A Dr. Baerlocher, Dr. Burington, Dr. Scarlett all s...
- Mon Dec 07, 2015 7:14 pm
- Forum: ImetelChat
- Topic: Piper Jaffrey raised Geron's price target from $5 to $10
- Replies: 0
- Views: 3470
Piper Jaffrey raised Geron's price target from $5 to $10
7 Dec 2015 Piper Jaffray on Monday issued a company note on Geron Corporation (NASDAQ: GERN) after news of new drug developments at the ASH 2015 conference. Piper Jaffray rates Geron as Overweight and raised the company's price target from $5.00 to $10.00. Analysts Charles Duncan and Sarah Weber wro...
- Sat Dec 05, 2015 2:00 pm
- Forum: ImetelChat
- Topic: IMerge recruiting in US and Netherlands
- Replies: 0
- Views: 3564
IMerge recruiting in US and Netherlands
MDS trial IMerge (34 locations) is no recruiting at two locations: Bethesda (Maryland, US) and Groningen (Netherlands). From the clinical trials site: Updated Nov. 30th Clinical Trials Identifier: NCT02598661 ( imetelstat Phase 2/3 ) Now Recruiting 2 locations - Recruiting Bethesda, Maryland, United...
- Fri Dec 04, 2015 2:21 pm
- Forum: ImetelChat
- Topic: Geron CEO to speak at Oppenheimer 9 Dec 2015
- Replies: 1
- Views: 2806
Geron CEO to speak at Oppenheimer 9 Dec 2015
John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at Oppenheimer 26th Annual Healthcare Conference in New York at 9:45 a.m. ET on December 9, 2015. The live and archived webcast will be available at http://www.veracast.com/webcasts/opco/healthcare2015/84203554236...